BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21243477)

  • 1. New frontiers in endocrinology of eating disorders.
    Monteleone P
    Curr Top Behav Neurosci; 2011; 6():189-208. PubMed ID: 21243477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunctions of leptin, ghrelin, BDNF and endocannabinoids in eating disorders: beyond the homeostatic control of food intake.
    Monteleone P; Maj M
    Psychoneuroendocrinology; 2013 Mar; 38(3):312-30. PubMed ID: 23313276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrinology and brain imaging of reward in eating disorders: A possible key to the treatment of anorexia nervosa and bulimia nervosa.
    Monteleone AM; Castellini G; Volpe U; Ricca V; Lelli L; Monteleone P; Maj M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt B):132-142. PubMed ID: 28259721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine dysregulation of food intake in eating disorders.
    Monteleone P; Castaldo E; Maj M
    Regul Pept; 2008 Aug; 149(1-3):39-50. PubMed ID: 18582958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible involvement of brain-derived neurotrophic factor in eating disorders.
    Nakazato M; Hashimoto K; Shimizu E; Niitsu T; Iyo M
    IUBMB Life; 2012 May; 64(5):355-61. PubMed ID: 22473707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From disordered eating to addiction: the "food drug" in bulimia nervosa.
    Umberg EN; Shader RI; Hsu LK; Greenblatt DJ
    J Clin Psychopharmacol; 2012 Jun; 32(3):376-89. PubMed ID: 22544008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ghrelin in eating disorders.
    Yi CX; Heppner K; Tschöp MH
    Mol Cell Endocrinol; 2011 Jun; 340(1):29-34. PubMed ID: 21453750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ghrelin gene variants and eating disorders.
    Ando T
    Vitam Horm; 2013; 92():107-23. PubMed ID: 23601422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower levels of cannabinoid 1 receptor mRNA in female eating disorder patients: association with wrist cutting as impulsive self-injurious behavior.
    Schroeder M; Eberlein C; de Zwaan M; Kornhuber J; Bleich S; Frieling H
    Psychoneuroendocrinology; 2012 Dec; 37(12):2032-6. PubMed ID: 22542985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic susceptibility to eating disorders: associated polymorphisms and pharmacogenetic suggestions.
    Monteleone P; Maj M
    Pharmacogenomics; 2008 Oct; 9(10):1487-520. PubMed ID: 18855537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of brain-derived neurotrophic factor in eating disorders: recent findings and its pathophysiological implications.
    Hashimoto K; Koizumi H; Nakazato M; Shimizu E; Iyo M
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):499-504. PubMed ID: 15866349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the Peripheral Endocannabinoid System as a Risk Factor for the Development of Eating Disorders.
    Capasso A; Milano W; Cauli O
    Endocr Metab Immune Disord Drug Targets; 2018; 18(4):325-332. PubMed ID: 29437028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approach and avoidance motivation in eating disorders.
    Harrison A; Treasure J; Smillie LD
    Psychiatry Res; 2011 Aug; 188(3):396-401. PubMed ID: 21645929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A ghrelin gene variant may predict crossover rate from restricting-type anorexia nervosa to other phenotypes of eating disorders: a retrospective survival analysis.
    Ando T; Komaki G; Nishimura H; Naruo T; Okabe K; Kawai K; Takii M; Oka T; Kodama N; Nakamoto C; Ishikawa T; Suzuki-Hotta M; Minatozaki K; Yamaguchi C; Nishizono-Maher A; Kono M; Kajiwara S; Suematsu H; Tomita Y; Ebana S; Okamoto Y; Nagata K; Nakai Y; Koide M; Kobayashi N; Kurokawa N; Nagata T; Kiriike N; Takenaka Y; Nagamine K; Ookuma K; Murata S;
    Psychiatr Genet; 2010 Aug; 20(4):153-9. PubMed ID: 20421852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoids and the non-homeostatic control of appetite.
    Kirkham TC
    Curr Top Behav Neurosci; 2009; 1():231-53. PubMed ID: 21104386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocircuit function in eating disorders.
    Friederich HC; Wu M; Simon JJ; Herzog W
    Int J Eat Disord; 2013 Jul; 46(5):425-32. PubMed ID: 23658085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perplexities and provocations of eating disorders.
    Halmi KA
    J Child Psychol Psychiatry; 2009 Jan; 50(1-2):163-9. PubMed ID: 19220599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Predictors of symptomatic improvement in eating disorders. Preliminary analysis].
    Cygankiewicz P; Solecka D; Pilecki MW; Józefik B
    Psychiatr Pol; 2012; 46(2):201-12. PubMed ID: 23214391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural processing of negative word stimuli concerning body image in patients with eating disorders: an fMRI study.
    Miyake Y; Okamoto Y; Onoda K; Shirao N; Okamoto Y; Otagaki Y; Yamawaki S
    Neuroimage; 2010 Apr; 50(3):1333-9. PubMed ID: 20045473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetics of eating disorders.
    Helder SG; Collier DA
    Curr Top Behav Neurosci; 2011; 6():157-75. PubMed ID: 21243475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.